Refinement of prognosis and the effect of azacitidine in intermediate-risk myelodysplastic syndromes

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Cancer J
Autors principals: Liapis, Konstantinos, Papadopoulos, Vasileios, Vrachiolias, George, Galanopoulos, Athanasios G., Papoutselis, Menelaos, Papageorgiou, Sotirios G., Diamantopoulos, Panagiotis T., Pappa, Vassiliki, Viniou, Nora-Athina, Kourakli, Alexandra, Τsokanas, Dimitris, Vassilakopoulos, Theodoros P., Hatzimichael, Eleftheria, Bouronikou, Eleni, Ximeri, Maria, Pontikoglou, Charalambos, Megalakaki, Aekaterini, Zikos, Panagiotis, Panayiotidis, Panayiotis, Dimou, Maria, Karakatsanis, Stamatis, Papaioannou, Maria, Vardi, Anna, Kontopidou, Flora, Harchalakis, Nikolaos, Adamopoulos, Ioannis, Symeonidis, Argiris, Kotsianidis, Ioannis
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2021
Matèries:
Correspondence
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7878783/
https://ncbi.nlm.nih.gov/pubmed/33574231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-021-00424-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars